본문바로가기
Q
U
I
C
K

Science & Technology

SK bioscience provides various vaccine platforms based on the company's R&D and manufacturing capabilities.

R&D

The SK bioscience R&D Center is dedicated to various vaccine platforms
based on its advanced technology and research capabilities to develop vaccines
which will promote human health around the world.
Introduction of research technologies for various vaccine platforms.

Mouse over to see the status of vaccine development based on our research.

Platform Technologies
Cell line
Engineering
  • Suspension MDCK cell
  • Suspension Vero cell
Mammalian
Cell Culture
  • Suspension
  • Adherent
  • Microcarrier
Glyco
-conjugation
  • Fermentation
  • Conjugation
Genetic
Engineering
  • Baculovirus Expression
  • Genetic Recombination (including viral vector)
  • Reverse Genetics
  • cFlu
  • PCV
  • Zoster
  • Varicella
  • Rota
  • HPV
  • TCV
  • NRRV
  • MCV/MenB
  • Rota, Influenza, RSV
  • RSV, MERS, ZIKA, COVID19
  • Influenza, Rota, Polio, Rabies, JEV, Dengue, EV81, Yellow Fever, Hep A
  • iNTS
  • Pan-Sarbecovirus
  • Nasal Spray (Miniprotein)
Basic Research /
Preclinical
Phase Ⅰ/Ⅱ Phase Ⅲ BLA Commercial
Next generation
(with Sanofi Pasteur)